ENTA vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

ENTA

47.2
AI Score
VS
ENTA Wins

JBIO

32.9
AI Score

Investment Advisor Scores

ENTA

47score
Recommendation
HOLD

JBIO

33score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ENTA JBIO Winner
Net Income -81.89M -131.19M ENTA
Operating Income -85.35M -142.00M ENTA
ROE -126.5% -28.8% JBIO
ROA -29.2% -27.0% JBIO
Total Assets 280.73M 486.39M JBIO
Cash 32.30M 80.39M JBIO
Current Ratio 4.21 16.03 JBIO
Free Cash Flow -32.17M -96.84M ENTA

Relative Price Performance (Last 90 Days)

ENTA 1M: -4.2% · 3M: -14.3% JBIO 1M: +17.3% · 3M: -31.2%

Current Technical Phase

ENTA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.6 · Price: $10.99

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $16.14

Fundamentals Snapshot

Metric ENTA JBIO
Market Cap — —
Forward P/E -4.6 -6.1
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 1.0% —
Operating Margin -0.9% 0.0%
EPS -2.42 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ENTA is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.